Latest Articles
Recurrent Hemothorax and Hemoperitoneum in Endometriosis: A Case Report - Cureus
Recurrent Hemothorax and Hemoperitoneum in Endometriosis: A Case Report Cureus
Published: Aug. 6, 2025, 9:17 p.m.
Actress Janel Parrish Opens Up About Her Battle With Endometriosis - NewsBreak: Local News & Alerts
Actress Janel Parrish Opens Up About Her Battle With Endometriosis NewsBreak: Local News & Alerts
Published: Aug. 6, 2025, 8:40 p.m.
Actress Janel Parrish Opens Up About Her Battle With Endometriosis - Fangirlish
Actress Janel Parrish Opens Up About Her Battle With Endometriosis Fangirlish
Published: Aug. 6, 2025, 8 p.m.
Cardiff Council Commits to Becoming Endometriosis Friendly Employer - Business News Wales
Cardiff Council Commits to Becoming Endometriosis Friendly Employer Business News Wales
Published: Aug. 6, 2025, 4:44 p.m.
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers - The ASCO Post
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers The ASCO Post
Published: Aug. 6, 2025, 3:38 p.m.
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database - Frontiers
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database Frontiers
Published: Aug. 6, 2025, 2:27 p.m.
Mother with stage four endometriosis launches petition to raise awareness of ‘painful’ condition in schools - Northampton Chronicle and Echo
Mother with stage four endometriosis launches petition to raise awareness of ‘painful’ condition in schools Northampton Chronicle and Echo
Published: Aug. 6, 2025, 1:37 p.m.
NICE approves first immunotherapy combination for endometrial cancer - Wired Gov
NICE approves first immunotherapy combination for endometrial cancer Wired Gov
Published: Aug. 6, 2025, 1:13 p.m.
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences The Globe and Mail
Published: Aug. 6, 2025, 1:11 p.m.
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central
First immunotherapy combination for endometrial cancer approved by NICE Oncology Central
Published: Aug. 6, 2025, 11:18 a.m.
Link copied to clipboard!